Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 14;12(7):938.
doi: 10.3390/pathogens12070938.

Rates of Seroprotection against Vaccine-Preventable Infectious Diseases in HIV-Exposed and -Unexposed Malawian Infants

Affiliations

Rates of Seroprotection against Vaccine-Preventable Infectious Diseases in HIV-Exposed and -Unexposed Malawian Infants

Silvia Baroncelli et al. Pathogens. .

Abstract

Background: The evaluation of seroprotection rates against vaccine-preventable infectious diseases allows for the identification of risk populations. HIV-exposed infants, even if not infected with HIV, have higher morbidity and mortality in comparison to unexposed counterparts. The aim of this study was to compare the specific IgG levels against Haemophilus influenzae type-B (HiB), Hepatitis-B (HBV), and Streptococcus pneumoniae (Spn) in two groups of infants (HIV-exposed and HIV-unexposed) living in Malawi.

Methods: Blood samples from 62 infants, 49 HIV-exposed, uninfected (HEU), and born to women living with HIV and 13 HIV-unexposed and uninfected (HUU), were collected at 6 months, and specific IgG levels were determined using ELISA tests.

Results: The antibody levels against HiB, HBV, and Spn were similar in the two groups. At six months, all HUU infants and 81.6% of HEU infants showed seroprotective levels against HiB, while a percentage of protection varying from 80.6 to 84.6% was observed for HBV and Spn regardless of HIV exposure. Only 59.2% of HEU and 69.2% of HUU infants showed antibody protection against all three pathogens.

Conclusions: These results indicate similar rates of seroprotection among HEU and HUU infants but also suggest that a consistent fraction of infants received incomplete vaccinations. Strategies to enforce participation in immunization programs in Malawi should be a health priority.

Keywords: Africa; HIV in utero-exposition; Haemophilus influenzae type B; IgG protective levels; Streptococcus pneumoniae; hepatitis B; infants; vaccine-preventable diseases.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Rates of infants with protective antibody levels (HiB > 0.15 mg/L, HBV > 10.0 mUI/mL, and S. pneumoniae ≥ 50 mg/L) against the three pathogens among HEU and HUU groups. Blue: No protective levels against any pathogen. Dotted: Protective levels against only 1 pathogen. Diagonal stripes: Protective levels against 2 out of 3 pathogens. Yellow: Protective levels against all 3 pathogens.

References

    1. The World Data Bank, 2022 Prevalence of HIV, Total (% of Population Ages 15–49)—Malawi. [(accessed on 3 May 2023)]. Available online: https://data.worldbank.org/indicator/SH.DYN.AIDS.ZS?locations=MW.
    1. UNICEF Data: Monitoring the Situation of Children and Women 2021. [(accessed on 3 May 2023)]. Available online: https://data.unicef.org/topic/child-survival/under-five-mortality/
    1. UNAIDS—Malawi Country Factsheet. 2020. [(accessed on 6 February 2023)]. Available online: https://www.unaids.org/en/regionscountries/countries/malawi.
    1. World Health Organization Regional Office for Africa 2014 T Implementation of Option B+ for Prevention of Mother-to-Child Transmission of HIV: Malawi Experience. [(accessed on 15 March 2023)]. Available online: https://www.afro.who.int/sites/default/files/2017-07/implementation-of-o....
    1. Redinger S., Udedi E., Richter L.M., Dovel K.L., Bruns L., Coates T.J., Rochat T.J. Double benefit? Integrating an early childhood development programme into HIV PMTCT Option B+ services in Malawi. AIDS Care. 2021;33:1595–1602. doi: 10.1080/09540121.2021.1876834. - DOI - PubMed

LinkOut - more resources